234 related articles for article (PubMed ID: 33097254)
21. Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis.
Lv YC; Tang YY; Zhang P; Wan W; Yao F; He PP; Xie W; Mo ZC; Shi JF; Wu JF; Peng J; Liu D; Cayabyab FS; Zheng XL; Tang XY; Ouyang XP; Tang CK
PLoS One; 2016; 11(6):e0157265. PubMed ID: 27295295
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis.
Sun R; Zhang L
Biomed Pharmacother; 2019 Mar; 111():1036-1045. PubMed ID: 30841417
[TBL] [Abstract][Full Text] [Related]
23. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-β1/Smads signaling in diabetic cardiomyopathy.
Che H; Wang Y; Li H; Li Y; Sahil A; Lv J; Liu Y; Yang Z; Dong R; Xue H; Wang L
FASEB J; 2020 Apr; 34(4):5282-5298. PubMed ID: 32067273
[TBL] [Abstract][Full Text] [Related]
24. Catalpol attenuates cardiomyocyte apoptosis in diabetic cardiomyopathy via Neat1/miR-140-5p/HDAC4 axis.
Zou G; Zhong W; Wu F; Wang X; Liu L
Biochimie; 2019 Oct; 165():90-99. PubMed ID: 31078585
[TBL] [Abstract][Full Text] [Related]
25. Sirtuin 3 Alleviates Diabetic Cardiomyopathy by Regulating TIGAR and Cardiomyocyte Metabolism.
Li L; Zeng H; He X; Chen JX
J Am Heart Assoc; 2021 Feb; 10(5):e018913. PubMed ID: 33586458
[TBL] [Abstract][Full Text] [Related]
26. Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo.
Yang T; Gu H; Chen X; Fu S; Wang C; Xu H; Feng Q; Ni Y
J Surg Res; 2014 Dec; 192(2):317-25. PubMed ID: 25085702
[TBL] [Abstract][Full Text] [Related]
27. Silencing lncRNA GAS5 alleviates apoptosis and fibrosis in diabetic cardiomyopathy by targeting miR-26a/b-5p.
Zhu C; Zhang H; Wei D; Sun Z
Acta Diabetol; 2021 Nov; 58(11):1491-1501. PubMed ID: 34091757
[TBL] [Abstract][Full Text] [Related]
28. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
29. Tom70 protects against diabetic cardiomyopathy through its antioxidant and antiapoptotic properties.
Wang P; Wang D; Yang Y; Hou J; Wan J; Ran F; Dai X; Zhou P; Yang Y
Hypertens Res; 2020 Oct; 43(10):1047-1056. PubMed ID: 32724135
[TBL] [Abstract][Full Text] [Related]
30. miR-200a-3p overexpression alleviates diabetic cardiomyopathy injury in mice by regulating autophagy through the FOXO3/Mst1/Sirt3/AMPK axis.
You P; Chen H; Han W; Deng J
PeerJ; 2023; 11():e15840. PubMed ID: 37727684
[TBL] [Abstract][Full Text] [Related]
31. LncRNA JPX targets SERCA2a to mitigate myocardial ischemia/reperfusion injury by binding to EZH2.
Bao J; Zhang C; Chen J; Xuan H; Wang C; Wang S; Yin J; Liu Y; Li D; Xu T
Exp Cell Res; 2023 Jun; 427(1):113572. PubMed ID: 36990422
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis.
Hu H; Wu J; Li D; Zhou J; Yu H; Ma L
Biomed Pharmacother; 2018 Oct; 106():738-746. PubMed ID: 29990866
[TBL] [Abstract][Full Text] [Related]
33. lncRNA‑MALAT1 promotes high glucose‑induced H9C2 cardiomyocyte pyroptosis by downregulating miR‑141‑3p expression.
Wu A; Sun W; Mou F
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576445
[TBL] [Abstract][Full Text] [Related]
34. lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy.
Li X; Wang H; Yao B; Xu W; Chen J; Zhou X
Sci Rep; 2016 Oct; 6():36340. PubMed ID: 27796346
[TBL] [Abstract][Full Text] [Related]
35. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
[TBL] [Abstract][Full Text] [Related]
36. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
[TBL] [Abstract][Full Text] [Related]
37. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TINCR is downregulated in diabetic cardiomyopathy and relates to cardiomyocyte apoptosis.
Chen Y; Tan S; Liu M; Li J
Scand Cardiovasc J; 2018 Dec; 52(6):335-339. PubMed ID: 30453794
[TBL] [Abstract][Full Text] [Related]
39. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
[TBL] [Abstract][Full Text] [Related]
40. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
